Radient Technologies Inc. (V:RTI*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
Company Contact
Address: 8223 Roper Road
EDMONTON AB T6E 6S4
Tel: N/A
Website: https://www.radientinc.com
IR: See website
<
Key People
Harry Kaura
President, Chief Executive Officer, Director
Prakash Hariharan
Chief Financial Officer
Steven Joseph Splinter
Chief Technology Officer, Corporate Secretary, Director
Business Overview
Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.
Financial Overview
For the nine months ended 31 December 2022, Radient Technologies Inc revenues decreased 14% to C$2.9M. Net loss decreased 24% to C$5.2M. Revenues reflect Manufacturing services decrease from C$17K to C$0K. Lower net loss reflects Production plant decrease of 69% to C$431K (expense), Gain on modification of long-term debt decrease from C$595K (expense) to C$248K (income).
Employees: 33 as of Mar 31, 2020
Reporting Currency: Canadian Dollars
Enterprise value: $16.32M as of Dec 31, 2022
Annual revenue (TTM): $3.15M as of Dec 31, 2022
EBITDA (TTM): -$4.80M as of Dec 31, 2022
Net annual income (TTM): -$11.30M as of Dec 31, 2022
Free cash flow (TTM): -$0.98M as of Dec 31, 2022
Net Debt Last Fiscal Year: $13.47M as of Dec 31, 2022
Shares outstanding: 541,000,000 as of Mar 4, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.